IMS Health chief nabs $25.9M in pay, topping J&J and Pfizer; Janssen's Stelara wins NICE nod for psoriatic arthritis;

@FiercePharma: ICYMI Friday: England to provide $GSK MenW vaccine to 3 million teens. FierceVaccines story | Follow @FiercePharma

@EricPFierce: GAO says FDA and DEA need to play better. The 2 can't even agree on what constitutes a drug shortage. FiercePharmaManufactuing article | Follow @EricPFierce

@CarlyHFierce: Endo Withdraws Proposal for Salix. Release | Follow @CarlyHFierce

> IMS Health Holdings ($IMS) gave its CEO a big pay boost for 2014, with a compensation package totaling $25.9 million, more than some of the biggest healthcare CEOs collect; the company went public last year, and CEO Ari Bousbib won a big stock award ahead of that offering. Report

> Johnson & Johnson's ($JNJ) anti-inflammatory drug Stelara won a thumbs up from U.K. cost-effectiveness watchdogs as a treatment for psoriatic arthritis. Report

> India's Lupin inked a deal to buy an additional 40% stake in the South African company Pharma Dynamics, gaining full control of the company in the process. Report

> The world's top 15 pharma companies saw their collective revenue drop to $546 billion from $555 billion last year, as the number of blockbuster meds dropped to 95 from 105. Report

Medical Device News

@FierceMedDev: Metabolon rides on last year's success with $5M in extended financing. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: FDA expands indication of the only sublingual second-gen antipsychotic. FierceDrugDelivery article | Follow @VarunSaxena2

@EmilyWFierce: ICYMI: Metabolon rides on last year's success with $5M in extended financing. Story | Follow @EmilyWFierce

> St. Jude releases promising data on its heart failure system. Article

> Edwards and Medtronic turn up TAVR competition with positive study data. News

Biotech News

@FierceBiotech: Cidara Therapeutics makes a quick leap into the growing Q1 IPO queue. News | Follow @FierceBiotech

@JohnCFierce: We're up to about 600 responses to our bull vs. bubble survey. Today's your last shot at participating. Survey | Follow @JohnCFierce

@DamianFierce: Fun fact: The NEJM paper that got PCSK9 blockade rolling was published just nine years ago. Paper | Follow @DamianFierce

> Pulmatrix backs its way onto Wall Street with merger deal. Story

> Chiasma taps a new CEO as it rolls toward an FDA filing. Item

> R&D exec Tal Zaks leaps from flagging Sanofi to fast-growing Moderna. Report

Animal Health News

> Aratana Therapeutics reports lower Q4, full-year 2014 financials. News

> USDA to launch national equine study this spring. Item

> Hedge fund snaps up 5% of Valeant amid speculation of a Zoetis deal. More

> New FDA report finds banned antibiotics still showing up in dairy cow tests. Story

> USDA head calls halt to any new experiments at Nebraska facility. Article

Biotech IT News

> Y Combinator backs cancer drug combo testing service. Story

> Genomics England doles out $12M as sequencing yields early breakthroughs. More

> Google adds Tute database to burgeoning Genomics platform. Report

> UCB to host epilepsy digital tool hackathon. Item

> Apple turns 700M iPhone users into potential participants in massive virtual trials. Article

And Finally... An increase in fatty liver disease--and testing of new meds to treat it--have diagnostics makers looking for better methods of identifying the malady. Report